Objectives: Decreased renal function is associated with increased cardiovascular risk. Our study was planned to verify the association of decreased renal function and subclinical coronary atherosclerosis in postmenopausal women. Methods: We performed a retrospective review of 251 Korean postmenopausal women who visited the health promotion center for a routine health checkup. Estimated glomerular filtration rate (eGFR) was used to show renal function, which was estimated by calculated using the Cockcroft-Gault (CG) and the modification of diet in renal disease (MDRD) formulas. Coronary atherosclerosis was assessed by 64-row multidetector computed tomography. 
Introduction
In postmenopausal women, cardiovascular disease (CVD) is major reason of morbidity and mortality. 1 In the past, menopausal hormonal therapy (MHT) had been regarded to have effect of preventing CVD, but several randomized controlled trials (RCTs) have shown that MHT does not reduce or slow the progression of established CVD.
2~5
Nowadays MHT is not recommended for the primary and secondary prevention of CVD.
Unlike RCTs, most observational studies support potential benefits of MHT in reducing risk of CVD.
Furthermore, reanalysis of RCT showed that starting MHT closer to menopause tended to reduce the risk of CVD J MM compared with starting MHT distant from menopause, which suggests determining start point of MHT could be important. 6 However, when the endothelium is involved with atherosclerosis already, it is too late for estrogen to exert a beneficial effect. 7 Therefore, risk assessment of atherosclerosis among postmenopausal women is important to enhance primary prevention of CVD and to minimize adverse effects of MHT.
CVD is common in patients with chronic kidney disease regardless of age and stage of kidney disease. There is now evidence that decreased renal function (estimated glomerular filtration rate [eGFR] < 60 mL/minute/1.73 m 2 ) is associated with cardiovascular events in general populations as well as high-risk groups. 8 Therefore, screening for early kidney function impairment assessed by glomerular filtration rate (GFR) may help to detect patients at increased cardiovascular risks. Previous our study showed that postmenopausal women with decreased renal function are more likely to have increased arterial stiffness which reflects the severity of vascular damage. 9 In addition, arterial stiffness measured by brachial-ankle pulse wave velocity (baPWV)
had high predictive values for coronary atherosclerosis in postmenopausal women. 10 These results suggest that assessing renal function using eGFR can be an economical and convenient method for assessment of cardiovascular risks in postmenopausal women.
However, it has not been evaluated whether renal function assessed by eGFR may reflect cardiovascular risk in postmenopausal women. The purpose of the current study is to investigate the association of decreased renal function with subclinical coronary atherosclerosis in postmenopausal women. 
Materials and Methods

Renal function
The GFR (mL/minute/1.73 m 4. baPWV measurement PWV was measured using the automatic waveform analyzer (BP-203RPE; Colin Co., Komaki, Japan) in accordance with a previously described method. 10 The interoperator and intra-operator variation were less than 5.0%
of coefficient. The mean values for the right and left baPWV were used for statistical analyses.
Coronary artery assessment
Cardiac MDCT was done using a 64-MDCT scanner (Philips Brilliance 64; Philips Medical System, Best, the Netherlands). The method of performance for the MDCT was in accordance with a previous described method. 10 Univariate and multivariate regression analysis were done to find the independent parameters in the presence of decreased renal function. Logistic regression analysis was done to assess the independent influence of renal function on detection of coronary atherosclerosis. A P value less than 0.05 was considered to be statistically significant.
Results Table 1 shows general characteristics of decreased renal function group and normal renal function group. Age and baPWV were significantly higher in decreased renal function group than in normal renal function group. Body mass index (BMI) was significantly higher in normal renal function group than in decreased renal function group (Table 1) . Table 2) . Association between eGFR and baPWV is persisted in normal renal function group, but not in decreased renal function group (Fig. 1) . Multivariate regression analysis revealed that the eGFR was significantly positively associated with BMI (β = 0.416, P < 0.001), and negatively associated with FSH (β = -0.113, P = 0.043) and baPWV (β = -0.352, P < 0.001) ( Table 3) . Table 4 shows general characteristics of atherosclerosis group and control group. Age and systolic blood pressure (SBP) were significantly higher in women with coronary atherosclerosis than in normal control women. HDLcholesterol and eGFR were significantly lower in women with coronary atherosclerosis than in normal control women (Table 4) . (Table 5 ).
Discussion
We evaluated the relationship between decreased renal CVD is the number one health risk to women which is caused by age, genetic influences, hypertension, diabetes, obesity and smoking. 13 Along with these risk factors, menopause causes women to face many physical as well as psychosocial problems. 14 To mitigate these postmenopausal symptoms, estrogen therapy could be an option in postmenopausal women, and previous study has reported that serum estradiol level might be associated with the degree of calcification of coronary artery in postmenopausal women. 15 Besides estrogen therapy, renal function is also alleged to In practice, there are some limitations in this study.
First, it has a limitation coming from the nature of retrospective study. Although several putative mechanisms were mentioned, we could not demonstrate the causal relationship between renal function and atherosclerosis.
Appropriate long-term follow-up and prospective study is needed to investigate the effects of decreased renal function on development of atherosclerosis in postmenopausal women. Second, the relatively small number of participants impeded our efforts to arrive at a valid conclusion about the association between renal function and atherosclerosis.
Lastly, eGFR by CG or MDRD has error compared to GFR measured by collecting 24 hour urine. In recent years, cystatin C is becoming more widely available and provides improved estimates of kidney function. Therefore, a newer kidney function marker would be required for future clinical practice.
Age and/or menopausal period is strongly associated with vascular damage (stage of atherosclerosis), and that also has been strongly accepted widely, therefore initiating MHT before vascular damage may be important factor in reducing CVD. Developing screening tool of subclinical atherosclerosis should be taken into account importantly to determine starting MHT before vascular damage development. To our knowledge, eGFR is a simple, cheap and convenient screening tool not only filtering high risk group of CVD, but also detecting atherosclerosis which could help to determine initiating MHT in postmenopausal women.
